Insurance

SamsungFire&MarineInsurance Hosts 'Car Meet' Automotive Culture Festival… Featuring Classic Cars, Tuned Cars, and More

PARK JONG-HWA
2026-08-06 08:28:06
[Edaily Reporter PARK JONG-HWA ] SamsungFire&MarineInsurance announced on the 6th that it will host “Night Car Meet,” a nighttime car culture festival, in front of the Mobility Museum exhibition hall in Yongin, Gyeonggi Province, from 6:00 p.m. to 8:00 p.m. on the 8th.

“Car Meet” is a cultural event where car enthusiasts display their vehicles and interact with one another. This year’s event will feature car clubs such as “20th Century 4WD,” “W140 Cafe,” “S2000 KOREA,” and the “Daewoo Motor Preservation Research Institute,” which will display vintage cars, classic cars, and tuned cars. Additionally, the event will be held in conjunction with the “Motor Festival” taking place at a nearby speedway, and free shuttle buses will operate between the two venues.

A representative from the SamsungFire&MarineInsurance Mobility Museum stated, “This Night Car Meet was organized so that not only car enthusiasts but also families visiting the museum during summer vacation can enjoy it together,” adding, “We plan to continue introducing various programs that allow people to experience automotive culture and the value of mobility in a more accessible way.”

Economy

Corporation

IT·Science

Economy

[Market In] Turning to Bank Loans Instead of Corporate Bonds… Will Even A-Rated Companies Turn Their Backs on the Bond Market Next Year?

The slump in the non-investment-grade corporate bond market—which has been centered on BBB-rated bonds this year—is expected to spread to A-rated companies next year. As the burden of issuing corporat…
2026-11-14 16:05:05

Corporation

Rookie Baropharm and Embattled Moalife Plus Face Paradoxical Volatility as GC Genome Anchors the Market [K-Bio Pulse]

Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
2026-11-14 12:47:03

IT·Science

Samsung BioLogics Sees 96.8% Subscription Rate for 2.7 Trillion Won Rights Offering… Hanmi MASH New Drug Phase 2b Results [Weekly Biotech Roundup]

(Graphic: ChatGPT) During the second week of November (Nov. 9–13), the domestic pharmaceutical and biotech industry saw significant attention focused on the success of SAMSUNG BIOLOGICS(207940)’s …
2026-11-15 08:01:02